Imunon (IMNN) Current Deferred Revenue (2013 - 2022)
Imunon's (IMNN) quarterly Current Deferred Revenue came in at $125000.0 in Q3 2022, down 75.0% YoY from $500000.0 in Q3 2021, and down 50.0% on a QoQ basis from $250000.0 in Q2 2022.
Imunon (IMNN) Current Deferred Revenue (2013 - 2022) Analysis & Trends
Imunon (IMNN) has 10 years of Current Deferred Revenue data on file, last reported at $125000.0 in Q3 2022.
- Quarterly Current Deferred Revenue fell 75.0% year-over-year to $125000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $125000.0 (down 75.0% YoY) and the FY2021 annual result came in at $500000.0, changed 0.0% from the prior year.
- Current Deferred Revenue declined to $125000.0 in Q3 2022, from $250000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $500000.0 in Q1 2018 to a low of $125000.0 in Q3 2022.
- A 5-year average of $460526.3 and a median of $500000.0 in 2018 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 0.0% in 2018, down 80.0% in 2018.
- Tracing IMNN's Current Deferred Revenue over 5 years: stood at $500000.0 in 2018, then changed by 0.0% to $500000.0 in 2019, then changed by 0.0% to $500000.0 in 2020, then changed by 0.0% to $500000.0 in 2021, then slumped by 75.0% to $125000.0 in 2022.
- The last three Current Deferred Revenue figures came in at $125000.0 (Q3 2022), $250000.0 (Q2 2022), and $375000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 375,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 500,000.00 |
| Mar 31, 2018 | 500,000.00 |
| Dec 31, 2017 | 2.50 Mn |